A quiet stiffness that lingers a little longer each year. For many, joint pain does not arrive suddenly but builds slowly over time, reshaping daily routines in subtle but frustrating ways.
Now, researchers are exploring whether that slow decline could one day be reversed.
A different approach
Scientists at the University of Colorado Boulder are testing an experimental injection aimed at repairing joint damage rather than easing symptoms.
Early animal studies, reported by ScienceAlert, suggest the method may stimulate the body to rebuild cartilage and bone tissue within weeks.
Also read: Food authority advises against new potatoes for infants
The treatment uses a slow-release system placed inside the joint. Instead of replacing tissue, it activates the body’s own repair mechanisms, encouraging cells to restore damaged areas.
Further testing is underway to assess safety before potential human trials.
Limited options
Osteoarthritis remains one of the most widespread joint conditions globally, with no cure currently available. Patients often rely on pain management or, in more severe cases, joint replacement surgery.
Researchers are also developing an injectable scaffold that helps support new cartilage growth.
Also read: How protein powder can affect your body if you take it every day
The goal is to create treatment options across different stages of the disease, from early wear to advanced degeneration.
Research expands
Interest in regenerative approaches is growing across the field. Other studies have identified biological drivers behind cartilage loss, while existing medications are being examined for their potential to protect joint tissue.
Key directions include:
- Stimulating natural cell repair
- Supporting cartilage regrowth
- Slowing degeneration through targeted drugs
Human trials could begin within the next 18 months, depending on upcoming results.
Also read: How raisins can affect your body if you eat them every day
Also read: New research: The gut may be key to slowing cognitive decline
This article is made and published by Mie Hermansen, who may have used AI in the preparation.